Skip to main content
Fig. 1 (abstract P-047). | BMC Proceedings

Fig. 1 (abstract P-047).

From: Abstracts from the 25th European Society for Animal Cell Technology Meeting: Cell Technologies for Innovative Therapies

Fig. 1 (abstract P-047).

Overview of improvements made for a mAb titer, b cell-specific mAb production rates (qP), c peak cell concentrations, and d the integral over the viable cell concentration (VCCD; viable cumulative cell days) at different steps during fed-batch strategy development. Each experimental result is shown by a coloured dot. Mean values of all experiments performed at one step are indicated by a black line

Back to article page